To improve the integrity and safety of horseracing by requiring a uniform anti-doping and medication control program to be developed and enforced by an independent Horseracing Anti-Doping and Medication Control Authority.
Actions Overview (1)
Date
05/25/2017
Introduced in House
05/25/2017 Introduced in House
All Actions (4)
Date
06/22/2018
Subcommittee Hearings Held. Action By: House Commerce Subcommittee on Digital Commerce and Consumer Protection
05/26/2017
Referred to the Subcommittee on Digital Commerce and Consumer Protection. Action By: Committee on Energy and Commerce
05/25/2017
Referred to the House Committee on Energy and Commerce. Action By: House of Representatives
05/25/2017
Introduced in House Action By: House of Representatives
06/22/2018 Subcommittee Hearings Held.
05/26/2017 Referred to the Subcommittee on Digital Commerce and Consumer Protection.
05/25/2017 Referred to the House Committee on Energy and Commerce.
Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.
Committee / Subcommittee
Date
Activity
Reports
House Energy and Commerce
05/25/2017
Referred to
House Commerce Subcommittee on Digital Commerce and Consumer Protection
05/26/2017
Referred to
06/22/2018
Hearings by
Related Bills (0)
No related bill information was received for H.R.2651.
This bill establishes the Horseracing Anti-Doping and Medication Control Authority as an independent non-profit corporation with responsibility for developing and administering an anti-doping and medication control program for: (1) Thoroughbred, Quarter, and Standardbred horses that participate in horse races that have a substantial relation to interstate commerce, (2) such horse races, and (3) the personnel engaged in the care, training, or racing of such horses.
The Federal Trade Commission (FTC) shall have exclusive jurisdiction over all horse racing anti-doping and medication control matters. The Authority and such FTC jurisdiction shall terminate if an interstate compact providing for services consistent with such program is established within five years after the program takes effect.
The Authority may enter into agreements with state racing commissions to implement the program within their jurisdictions.
Program elements shall include:
anti-doping and medication control rules,
lists of permitted and prohibited substances and methods,
a prohibition on the administration of any such substance within 24 hours of a horse's next racing start, and
testing and laboratory standards.
The Authority shall:
develop, maintain, and publish such lists;
establish a list of anti-doping and medication control rule violations applicable to either covered horses or persons;
establish standards and the process for laboratory accreditation and sample testing; and
promulgate rules for anti-doping and medication control results management, for the disciplinary process for violation results management, and for imposing sanctions for violations.
The bill sets forth civil enforcement provisions.
Activities under this bill are funded by an assessment placed on state racing commissions based on the calculation of cost per racing starter.
All Summaries (1)
Shown Here: Introduced in House (05/25/2017)
Horseracing Integrity Act of 2017
This bill establishes the Horseracing Anti-Doping and Medication Control Authority as an independent non-profit corporation with responsibility for developing and administering an anti-doping and medication control program for: (1) Thoroughbred, Quarter, and Standardbred horses that participate in horse races that have a substantial relation to interstate commerce, (2) such horse races, and (3) the personnel engaged in the care, training, or racing of such horses.
The Federal Trade Commission (FTC) shall have exclusive jurisdiction over all horse racing anti-doping and medication control matters. The Authority and such FTC jurisdiction shall terminate if an interstate compact providing for services consistent with such program is established within five years after the program takes effect.
The Authority may enter into agreements with state racing commissions to implement the program within their jurisdictions.
Program elements shall include:
anti-doping and medication control rules,
lists of permitted and prohibited substances and methods,
a prohibition on the administration of any such substance within 24 hours of a horse's next racing start, and
testing and laboratory standards.
The Authority shall:
develop, maintain, and publish such lists;
establish a list of anti-doping and medication control rule violations applicable to either covered horses or persons;
establish standards and the process for laboratory accreditation and sample testing; and
promulgate rules for anti-doping and medication control results management, for the disciplinary process for violation results management, and for imposing sanctions for violations.
The bill sets forth civil enforcement provisions.
Activities under this bill are funded by an assessment placed on state racing commissions based on the calculation of cost per racing starter.
